|
Lopez-Lopez V, Gomez Ruiz A, Lopez-Conesa A, Brusadin R, Cayuela V, Caballero-Illanes A, Torres M, Robles Campos R. Effects of primary hypertension treatment in the oncological outcomes of hepatocellular carcinoma. Ann Transl Med. 2020 Jul;8(14):844. doi: 10.21037/atm.2020.04.40. No abstract available. PubMed PMID: 32793688; PubMed Central PMCID: PMC7396803.
AÑO: 2020; IF: 3.932
|
32793688
|
Robles-Campos R, Navarro-Barrios A, Martinez-Caceres C, Revilla-Nuin B, Brusadin R, Lopez-Lopez V, Lopez-Conesa A, Caballero-Planes A, de la Pena-Moral J, Parrilla-Paricio P. The Contribution of the Deportalized Lobe to Liver Regeneration in Tourniquet-ALPPS. Ann Surg. 2020 Mar;271(3):e94-e96. doi: 10.1097/SLA.0000000000003668. No abstract available. PubMed PMID: 31714308.
AÑO: 2020; IF: 12.969
|
|
Ruiz AJG, Lopez VL, Campos RR, Conesa AL, Brusadin R, Martinez DF, Paricio PP. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Tourniquet as a Resource for Hepatic Transplant in Patient With Hepatic Adenomatosis: A Case Report. Transplant Proc. 2020 Mar;52(2):594-595. doi: 10.1016/j.transproceed.2019.11.036. Epub 2020 Feb 6. PubMed PMID: 32033831.
AÑO: 2020; IF: 1.066
|
|
Robles-Campos R, Brusadin R, Lopez-Conesa A, Lopez-Lopez V, Navarro-Barrios A, Lopez-Espin JJ, Arevalo-Perez J, Parrilla P. Long-Term Outcome After Conventional Two-Stage Hepatectomy Versus Tourniquet-ALPPS in Colorectal Liver Metastases: A Propensity Score Matching Analysis. World J Surg. 2019 Sep;43(9):2281-2289. doi: 10.1007/s00268-019-05031-w. PubMed PMID: 31119359.
AÑO: 2019; IF: 2.234
|
|
Lopez-Lopez V, Robles-Campos R, Brusadin R, Lopez-Conesa A, de la Pena J, Caballero A, Arevalo-Perez J, Navarro-Barrios A, Gomez P, Parrilla-Paricio P. ALPPS for hepatocarcinoma under cirrhosis: a feasible alternative to portal vein embolization. Ann Transl Med. 2019 Nov;7(22):691. doi: 10.21037/atm.2019.10.57. PubMed PMID: 31930092; PubMed Central PMCID: PMC6944538.
AÑO: 2019; IF: 3.297
|